Pekka Taimen
MD, PhD
pepeta@utu.fi +358 29 450 4524 +358 50 431 1353 Kiinamyllynkatu 10 Turku Työhuone: D5019 ORCID-tunniste: https://orcid.org/0000-0001-8849-4604 Official web page of research group |
pathology; histology; cell biology; prostate cancer, bladder cancer, cardiomyopathy, nuclear lamin
Pekka Taimen received his MD degree from the University of Turku in 2001 and defended his thesis at the Department of Pathology, University of Turku in 2004. In 2008-2009 PT worked as a postdoctoral fellow in the laboratory of Prof. Robert D. Goldman, Northwestern University Medical School, Chicago. Postdoctoral studies focusing on nuclear intermediate filament proteins called lamins were further continued as a junior group leader after returning back to Turku in early 2010. In 2011 PT received a specialist degree in Pathology and since then he has worked as a part-time specialist at the Pathology Division, Turku University Hospital with special focus on uropathology. From 2012 PT has worked as a Clinical lecturer in Pathology and between 2015-2019 as a part-time Academy of Finland Clinical Researcher. PT was appointed as a tenure track Assistant Professor of Molecular Pathology in January 2019 and an Associate Professor in August 2020. In January 2022, PT was appointed as a Professor of Molecular Pathology and he currently serves as the head of the pathology unit at the Faculty of Medicine, University of Turku.
Professor Pekka Taimen has 20 years of experience in cell and molecular biology as well as in translational research. The main focus of his research group is on human diseases caused by lamin mutations, such as cardiomyopathies and premature aging syndrome. More recently, PT has also actively worked on prostate and bladder cancer related projects including novel biomarkers, biobanking, patient derived cell lines and improved imaging techniques utilizing digital pathology and machine learning approaches.
Pekka Taimen has more than 10 years of experience in teaching medical students at the Institute of Biomedicine, University of Turku. He has served first as a university teacher and from 2012 as a clinical lecturer. In 2015 PT received the Lecturer of the Year award in the Faculty of Medicine.
- (2019)
- International Journal of Hyperthermia
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - IMPROD biparametric MRI in men with a clinical suspicion of prostate cancer (IMPROD Trial): Sensitivity for prostate cancer detection in correlation with whole-mount prostatectomy sections and implications for focal therapyQuantitative Analysis of Nuclear Lamins Imaged by Super-Resolution Light Microscopy (2019)
- Journal of Magnetic Resonance ImagingCells
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Lamiinikardiomyopatia (2019)
- Sydänääni: Suomen Kardiologisen Seuran Lehti
(D1 Artikkeli ammattilehdessä) - Modeling of LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cells (2019)
- Cells
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells (2019)
- European Urology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Prebiopsy IMPROD Biparametric Magnetic Resonance Imaging Combined with Prostate-Specific Antigen Density in the Diagnosis of Prostate Cancer: An External Validation Study (2019)
- European Urology OncologyBJU International
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - (2019)
- Journal of Magnetic Resonance ImagingPLoS Medicine
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - (2019)
(B1 Vertaisarvioimaton kirjoitus tieteellisessä lehdessä ) - Radiomics and machine learning of multisequence multiparametric prostate MRI: Towards improved non-invasive prostate cancer characterization (2019)
- PLoS ONE
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Repeatability of radiomics and machine learning for DWI: Short-term repeatability study of 112 patients with prostate cancer (2019)
- Magnetic Resonance in MedicineDuodecim
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - (2019)
- European UrologyHuman Pathology
(O2 Muu julkaisu ) - (2019)
- Nature CommunicationsBMC Research Notes
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Urine cytology is a feasible tool for assessing erythematous bladder lesions after bacille Calmette-Guérin (BCG) treatment (2019)
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: A prospective multi-institutional trial (2019)
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - ANO7 is associated with aggressive prostate cancer (2018)
- International Journal of Cancer
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - C-11-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial) (2018)
- Cancer Imaging
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Intratumoral androgen levels are linked to TMPRSS2-ERG fusion in prostate cancer (2018)
- Endocrine-Related Cancer
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Laminopatiat - harvinaisten sairauksien kasvava joukko (2018)
(A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä) - New prostate cancer grade grouping system predicts survival after radical prostatectomy (2018)
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Pegylated and liposomal doxorubicin is associated with high mortality and causes limited cardiotoxicity in mice (2018)
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )



